Everolimus Granules – Available as Nanoparticles with 2.68% & 5% Strengths.
MKPPL is the first to come up with pellet based approach for immune suppressants.
Facilitates direct filling into capsules and can be easily employed in tableting. Nano particles can be effectively used for manufacturing of ointments (Tacrolimus) and solutions (Everolimus).
MKPPL pellet advantages includes using a micro emulsion technology. No cyclization of the drug, hence less delta lactones formation.
Coated pellets, hence the formulator does not require a contained facility for finished formulation.
Offer complete technical package for registrations in all regulated/semi regulated markets.
Mycophenolate Mofetil Pellets
Mycophenolate mofetil (MMF) is a immunosuppressant and product of mycophenolic acid, used extensively in transplant medicine, and it may play an increasing role in autoimmune disease. MMF has been introduced as a novel immunosuppressive agent in systemic lupus erythematosus (SLE), often in patients intolerant of or resistant to conventional immunosuppressive regimens.
Pimecrolimus Nano Particles
Sirolimus (initially known as Rapamycin) is a macrolide antibiotic with immunosuppressant properties. It is typically used to prevent rejection of organ transplantations especially in kidney transplants. Sirolimus has an anti-proliferative effect which makes it an effective treatment option for mesothelioma.
Tacrolimus Nano Solution
Tacrolimus IR Pellets
Tacrolimus IR Pellets 0.5%, 1%, 5% – Suitable for Capsules (Dose: 0.5 mg, 1 mg, 5 mg)
Tacrolimus is a potent immune suppressant. Tacrolimus is the first of the LIMUS based immunosuppressant to be marketed as a solid dosage capsule, infusion and ointment.
Murli Krishna Pharma’s technology addresses all the three formulations of Tacrolimus.
We do offer development services in case of a requirement for different formulation/dosage/strength
Offer complete technical package for registrations in all regulated/semi regulated markets
Products protected by ongoing Patents are not offered by MKPPL.